BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

VENENUM Biodesign Announces Opening of Medicinal Chemistry Labs


6/22/2011 8:36:45 AM

HAMILTON, N.J., June 22, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify potential therapeutic agents against its novel disease-based targets, or its partners' targets, announced today that it opened its new medicinal chemistry space at 8 Black Forest Road in Hamilton, NJ.

The facility comprises over 11,000 square feet of state-of-the-art research laboratories and office space. The space is used by VENENUM's chemists primarily for synthetic chemistry. In addition, VENENUM has a fully equipped analytical chemistry lab, a compound collection management lab, and an NMR lab housing a 400 MHz Bruker NMR spectrometer.

VENENUM Biodesign was established with the mission of improving patients' lives through the discovery of new therapeutic compounds. They are committed to building platforms for drug discovery research from novel targets to preclinical implementation. VENENUM Biodesign, a company within the Genesis Biotechnology Group, is located in "Einstein's Alley," the research and technology corridor in Hamilton, New Jersey. Their facility is easily accessible to other academic medical centers, biotech, and pharmaceutical companies in the New York, New Jersey, and Pennsylvania area.

The new facility at 8 Black Forest Road in Hamilton, NJ is a unique blend of upscale office space and state-of-the-art laboratory facilities designed with a specialized floor plan to accommodate the Biodesign compound collection which includes 5.5 million proprietary compounds (the "ECLiPS" library collection), six newly designed VENENUM Targeted Libraries (VTLs), and approximately 80,000 compounds from commercial sources. This small molecule collection is one of the largest in the world and, combined with VENENUM's state-of-the-art UHTS capabilities, is a powerful tool to generate quality leads for drug discovery.

The site also houses expansive laboratories to accommodate mammalian and yeast cell culture, siRNA technology, protein engineering and production, cellular reagent generation, structural biology, and in vitro assay and in vivo model development.

According to Dr. Maria Webb, Chief Scientific Officer (CSO), "VENENUM is well-positioned with full ranging 'Gene to Lead' capabilities in early drug discovery. We use our capabilities and unique technology to advance screening hits against our own novel targets to Pre-Clinical Development Candidates. We aim to partner these candidates with pharma in the next few years. In the interim, we are actively seeking collaborations in screening and medicinal chemistry areas to maximize the use of our technology and capabilities."

To find out more, please visit http://www.venenumbiodesign.com.

Contact:

Maria Webb, Ph.D.
Chief Scientific Officer (CSO)
mwebb@venenumbiodesign.com
877.950.1032
http://www.venenumbiodesign.com

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE VENENUM Biodesign



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES